Professor Gerardine Doyle
Thesis Title: VALue In Delivery of care for children with Cystic Fibrosis – VALID-CF Study
Research Interests: Value Based Healthcare, Health Outcomes, Health Literacy
Emma O’ Grady is the Senior Cystic Fibrosis (CF) Pharmacist at Children's Health Ireland (CHI) at Temple Street, Dublin. She is currently undertaking a PhD at UCD Smurfit Graduate Business School focused in Value Based Healthcare.
Ms. O’ Grady graduated with a BSc (Hons) in Chemistry at University College Dublin in 2007 before qualifying with a Masters in Pharmacy with Distinction from the Robert Gordon University in 2011. Following completion of her pre-registration training at Wishaw General Hospital, NHS Lanarkshire, she gained extensive experience as a Clinical Pharmacist in the UK and Ireland before being appointed as CF pharmacist at CHI at Temple Street in 2016.
In 2015 she was awarded a Post Graduate Diploma in Clinical Pharmacy with Distinction from Queens University, Belfast. The following year she was presented with a Masters in Clinical Pharmacy with Distinction from Queens University, Belfast. Her research thesis entitled “An Audit to assess Compliance with H-PIC/S National Guidelines for Aseptic Compounding in an Irish hospital pharmacy” was shortlisted as a finalist at the Irish Hospital Pharmacy Awards.
Her contributions to the care of people with CF in Ireland include the implementation of a CF Clinical Pharmacy service within the multidisciplinary team at CHI at Temple Street, and the development of local guidelines for the management of novel, highly effective modulator therapies as relevant to the paediatric population. She has presented at educational meetings on the safe management of CF therapies in Ireland, Europe and the Middle East. She is joint author of the clinical publication entitled “Evidence of Small Airways Disease and the Immediate Effects of Lumacaftor/Ivacaftor in Children with Cystic Fibrosis”. Her interests in highly effective therapies for people with CF extends to clinical trials and real world studies and she was the lead pharmacist in the implementation of a successful and on-going CF clinical trials programme in CHI at Temple Street.